Redusure™ IQP AK 102 is a patent-pending, highly purified proprietary complex of high-swelling capacity dietary fibres. The complex interacts synergistically to form an indigestible gel, which has a high level of viscosity. It can swell to 200 times its original size, and fills the stomach up to 43%. Redusure™ is clinically proven to be effective in promoting satiety for weight loss by reducing food intake. It also helps to control appetite and hunger-pangs to prevent snacking in-between meals. Redusure™ is an effective tool to treat and prevent excess weight with a well established safety profile and tolerability.
Satiety has been proven to be effective in obesity management. When Redusure™ is used in conjunction with reduced food intake and exercise, it helps to achieve improved weight management results by managing your satiety more effectively.
Every batch of Redusure™ is tested to ensure standardised quality and total traceability that guarantees safety-for-consumption. Products made with Redusure™ also deliver optimum swelling capacity for a high level of satiety.
International quality standards
Redusure™ is the result of years of scientific validation, stringent quality and proprietary processes. In the entire production of Redusure™, regular audits are conducted and documented in conformance with international requirements of Good Manufacturing Practice (GMP) guidelines, EN ISO 9001 and EN ISO 13485.
Safe for consumption
Redusure™ is a white powder that is odourless and tasteless with the ability to promote a feeling of satiety without any pharmacological, immunological or metabolic action or effects on the human body.
Redusure™ is a registered trademark of the InQpharm group of companies and is exclusively manufactured by InQpharm and distributed worldwide.